Digital Diabetes Global Market

–Forecast to 2026

Digital Diabetes Global Market estimated to be worth $16,329.6 million by 2026

IQ4I Research & Consultancy published a new report on “Digital Diabetes Global
Market – Forecast To 2026” This report analyzes and studies the overall market, major
Drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and
Rest of the World.

IQ4I’s Report Contains 88 market data tables and 120 figures spread through 404
pages and an exhaustive TOC on “digital diabetes global Market”, [PRODUCTS (Smart
Blood Glucose Monitoring, Continuous Glucose Monitoring {Sensors, Transmitter &
Receivers}, Smart Insulin Pump (Traditional, Patch), Smart Insulin Pens); END-USERS
(Homecare, Hospitals & Private clinics, and Others); REGION (North America {U.S., and
Rest of N.A.}, Europe {Germany, France, Italy and Rest of Europe}, Asia Pacific {Japan,
China, India and Rest of APAC}, and Rest of the World {Brazil, Rest of Latin America,
Middle East and Others})]

Digital diabetes includes products utilizing advanced technologies for monitoring, managing
and tools that help in deciding optimum therapy options in the patients suffering from
diabetes. These devices help in monitoring of blood sugar levels, calorie counting, and in
insulin dose calculation, reduce complications to improve the quality of life of diabetics.

According to IQ4I analysis, digital diabetes global market is expected to reach $16,329.6
million by 2026. The factors such as global rise in the prevalence and incidence of diabetes,
and technological advancement in digital diabetes devices are driving the market growth.
The growing diffusion of smart devices and digital platforms and increasing R&D
investments are providing opportunities for growth. Whereas, high cost associated with the
products, increasing product recall and inadequate reimbursements are restraining the
market growth. The threat for the digital diabetes market includes strict regulations from
various regulatory organizations across geographies, safety issues and privacy concerns.

Digital diabetes global market is segmented based on products, end-users and region.
Product category is segmented into devices, apps and software. As estimated by IQ4I
Research, the devices segment accounted for the largest revenue in 2019 and projected to
grow at mid single digit CAGR from 2019 to 2026 due to increasing incidence and
prevalence of diabetes, growing adoption of smart devices.

In the digital diabetes end-user market, homecare segment accounted for the largest share
in 2019 and this market is expected to grow at a high single digit CAGR from 2019 to 2026,
this can be mainly attributed to technological advancements, shift towards self-management

IQ4I Research & Consultancy Pvt. Ltd. Page 1

Digital Diabetes Global Market

–Forecast to 2026

of diabetes, the improvement and acceptance of home care devices. In addition, growing
focus of companies to increase awareness about diabetes and management devices & apps
are further driving the adoption in home care settings.

Among various geographic market segments, North America region commanded the largest
revenue in 2019 growing at a mid single CAGR from 2019 to 2026. Increased awareness of
the benefits of using continuous glucose monitoring systems, growing diffusion of smart
devices, and high incidences of obesity as well as diabetes are driving the market. However,
Asia-Pacific region is expected to grow at double digit CAGR from 2019 to 2026 due to
increasing patient awareness, increasing prevalence of diabetes cases due to unhealthy
lifestyle, poor diet, excess alcohol consumption and increase in penetration of digital
platform.

Approvals, agreements and acquisitions are driving the digital diabetes market growth. For
instance, in October 2019, Dexcom, inc. received FDA approval for Dexcom G6 Pro a CGM
system meant for healthcare specialists to assess the suitability for CGM therapy, ages two
years and up. It is the first and only single use, professional CGM that gathers real-time glucose
data over a 10 day period and offers both a blinded and unblinded mode. Similarly, In October
2019 LifeScan entered into collaboration with Willis Towers Watson to expand the adoption of
OneTouch Reveal plus, the digital diabetes therapeutic powered by Welldoc’s award winning
BlueStar Platform.

Considering the attractiveness of digital diabetes market, several venture capitalists are
aggressively investing in developing devices, apps and digital programs. According to IQ4I
analysis, funding received by digital diabetes companies during the period 2018-2019 was
worth $XX million. The funding is utilized to help pregnant woman at risk of developing Type
2 diabetes and expansion of digital care programs and expansion of biosensor patch for
CGM and also to develop hybrid closed loop automated insulin delivery app. For example in
September 2019, Liva Healthcare received $XX million funding from EU Horizon to help
pregnant woman at risk of Type 2 diabetes. Digital diabetes clinical trials data indicate
globally, XX% are in phase 2 and XX% are in phase 3. Majority of clinical trials are focused
on developing smart insulin pump and artificial pancreas such as hybrid closed loop devices.

Major players in the digital diabetes global market are Abbott Laboratories (U.S.), Dexcom,
Inc. (U.S.), Insulet Corporation (U.S.), i-Sens, Inc. (South Korea), Livongo Health, Inc. (U.S.),

IQ4I Research & Consultancy Pvt. Ltd. Page 2

Digital Diabetes Global Market

–Forecast to 2026

Medtronic PLC (Ireland), F.Hoffmann-LA Roche AG (Switzerland), Senseonics Holdings, Inc.

(U.S.), Tandem Diabetes Care (U.S.), and Ypsomed Holding AG (Switzerland).

Reasons for buying this report:

 Digital diabetes global market is expected to reach $16,329.6 million by 2026
growing at high single digit CAGR from 2019 to 2026.
 Identification and analysis of the digital diabetes market segments by products, end-
users and geography.
 Analysis of the global market by identifying various sub-segments of the digital
diabetes market.
 Revenue forecast of the digital diabetes market and strategic analysis of each
submarket with respect to individual growth trends.
 Revenue forecast of the digital diabetes market with respect to North America (U.S.
and Rest of N.A.), Europe (Germany, France, Italy and Rest of Europe), Asia-Pacific
(Japan, China, India and Rest of APAC) and RoW (Brazil, Rest of Latin America,
Middle East & Others) regions.
 Identification of the major market trends and factors driving or inhibiting the growth of
the digital diabetes global market and its various sub-markets.
 Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
 Analysis of the clinical trials and number of units sold such as Glucose testing strips,
CGM, Smart insulin pump, Smart insulin pen by region and country wise.
 Analysis of market penetration for smart insulin pumps and smart insulin pens in
case of both type 1 and type 2 diabetes.
 Porter’s analysis, funding scenario, deals (Collaboration, agreements, Partnership,
Acquisition)
 Profiles of major players in the digital diabetes with details of their product offerings,
business strategies, SWOTs, market shares for SBGM, CGM, Smart insulin pump,
Smart insulin pen, Apps and software, reimbursement, technological advancements
and supply chain analysis.

IQ4I Research & Consultancy Pvt. Ltd. Page 3

Digital Diabetes Global Market

–Forecast to 2026

FIGURE 1

DIGITAL DIABETES GLOBAL MARKET SEGMENTATION

Digital Diabetes Global Market

By Products By End Users By Geography

Apps & Hospitals & North

Devices
Softwares Pvt. clinics America

Home care Europe

Smart Insulin Smart Insulin
SMBG CGM
Pumps Pens Others APAC
Blood Glucose Traditional
Sensors
Meter Pumps
RoW
Blood Glucose Transmitter
Patch Pumps
Testing strips and Receivers

Lancets

Others

IQ4I Research & Consultancy Pvt. Ltd. Page 4